Delivery Order SPE2DB22D9239-SPE2DB25FDJ91
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency valued at $16,632.54 for the supply of Cabometyx 20 mg tablets (30-count). The contract, issued on May 12, 2025, with a completion date of May 13, 2025, operates under a firm fixed-price structure with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on September 25, 2025, for Cabometyx 40 mg tablets (30-count packages). This firm fixed-price delivery order, valued at $49,449.63, is expected to be completed by September 26, 2025, and represents performance at the vendor's Park Ridge facility. The award was made without a set-aside designation, allowing DMS...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency (DLA) for the supply of Cabometyx 40 mg tablets (30-count packages). This firm fixed-price delivery order, issued on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a discrete purchase under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,434.34 by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Cabometyx 60 mg tablets (30-count packaging). This firm fixed-price delivery order, which has an ultimate completion date of September 19, 2025, represents a single pharmaceutical product delivery under the company's existing indefinite delivery contract...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a firm fixed-price delivery order valued at $16,483.21 for Cabometyx 40 mg tablets (30-count units). The contract, awarded on September 15, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on June 18, 2025, by the Defense Logistics Agency (DLA) for Cabometyx 20 mg tablets (30-count units) with a ceiling value of $33,265.08. The award was made under a firm fixed-price contract type with no set-aside designation, with an ultimate completion date of June 20, 2025. This delivery order represents a purchase of pharmaceutical inventory to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $33,265.08 by the Defense Logistics Agency on September 19, 2025, for the supply of Cabometyx 20 mg tablets (30-count units). The contract, which carries no set-aside designation, is scheduled for completion by September 22, 2025, and is performed at the contractor's Park Ridge location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $32,966.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $33,265.08 for the supply of Cabometyx 20 mg tablets (30-count units) on September 2, 2025. This award, with an ultimate completion date of September 3, 2025, carries no set-aside designation and will be performed at the contractor's Park Ridge facility. The delivery order is funded by the Defense Logistics Agency's Medical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $16,483.21 by the Defense Logistics Agency on September 3, 2025, for the supply of Cabometyx 40 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, was issued without a set-aside designation. The award is issued under DMS Pharmaceutical Group's existing single-award...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDJ91Delivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on June 6, 2025, for the supply of Cabometyx 20 mg tablets (30-count units) with a ceiling value of $49.9K. This firm fixed-price delivery order is scheduled for ultimate completion by June 9, 2025, and represents a direct fulfillment of pharmaceutical supply needs for Department of Defense healthcare facilities. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits as an established federal contractor in the pharmaceutical distribution market. This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $500M and valid through November 2026. The IDC serves as the underlying vehicle enabling the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support military health facilities worldwide. As a consistent supplier to the DLA with an extensive portfolio of pharmaceutical contract awards, DMS Pharmaceutical Group maintains a critical position within the federal pharmaceutical supply chain for defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.9k | 6/6/25 |